Prevalence of AKI
During their chemotherapy treatment, 56 patients (50%) developed AKI
and 13 had a second AKI episode for a total of 69 AKI events during the
study period. Fifteen severe AKI episodes developed in 13 patients
(21.7%). The median time from the first visit to the first AKI and
median follow up time were 29.5 days (IQR 11-93) and 10.9 months (IQR
3.6-31.1), respectively. Figure 1 shows the maximum creatinine levels in
all AKI patients stratified by severity of AKI and age at diagnosis.